Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Herceptin 440mg


To avoid
Risk of oligohydramnios and fatal pulmonary hypoplasia in the fetus

Contraindicated
Herceptin 440mg :
Type Medicine Authorised
Originator Biotech (Herceptin 440mg)
Agent Omnipharma
Distributor Omnipharma
Laboratory Roche
Responsible Party F. Hoffmann La Roche Ltd
Origin Switzerland
Manufacturer Genentech Inc
Origin U.S.A.
ATC L01XC03
Revision Date 01/02/2012

Your comment will appear shortly after approval

Herceptin 440mg :

Revision Date : 01/02/2012


Effect Frequency
Abdominal pain Very Common
Acne Common
Acute pulmonary oedema Not known
Acute respiratory distress syndrome Not known
Alopecia Very Common
Anaemia Very Common
Anaphylactic reactions Very Common
Anaphylactic shock Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Anorexia Common
Anxiety Common
Arrhythmia Very Common
Arthralgia (Pain joint) (Joint ache) Very Common
Arthritis Very rare
Asthenia Very Common
Asthma Common
Ataxia Not known
Back pain Common
Bone pain Common
Bradycardia Not known
Bronchitis Not known
Bronchospasm Not known
Cardiac flutter Very Common
Cardiogenic shock Not known
Cardiomyopathy Very rare
Cellulitis Not known
Cephalea Very Common
Cerebral oedema (Brain oedema) Not known
Cerebrovascular disorders Not known
Chest pain Very Common
Cheyne-Stokes respiration Not known
Chills Very Common
Coma Not known
Congestive heart failure Common
Conjunctivitis Very Common
Constipation Very Common
Cough Very Common
Cystitis Common
Deafness Not known
Decreased appetite Very Common
Depression Common
Dermatitis Not known
Diarrhoea (Diarrhea) Very Common
Dry eye Common
Dry mouth (Xerostomia) Common
Dry skin Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Very Common
Dyspepsia Very Common
Dyspnoea (dyspnea) Very Common
Dyspnoea exertional Not known
Dysuria (Micturition painful) Not known
Ejection fraction decreased Common
Epistaxis (Nasal bleeding) Very Common
Erysipelas Not known
Erythema Very Common
Face oedema Very Common
Fatigue Very Common
Febrile neutropenia (Neutropenic fever) Common
Gallop rhythm Not known
Gastritis Not known
Glomerulonephritis Not known
Glomerulonephritis membranous Not known
Haemorrhage subcutaneous Common
Haemorrhoids Common
Hepatic failure (Hepatic insufficiency) (Liver failure) Not known
Hepatitis Common
Hepatocellular injury Not known
Herpes zoster Common
Hiccups Not known
Hot flush Common
Hyperhidrosis Common
Hyperkalaemia Not known
Hypersensitivity Common
Hypertension Very rare
Hypertonia Common
Hypoesthesia Very Common
Hypoprothrombinaemia Not known
Hypotension Common
Hypoxia Not known
Infection Common
Influenza Very rare
Influenza symptoms Very Common
Infusion related reaction Very Common
Insomnia Very Common
Interstitial pneumonitis Not known
Jaundice Not known
Lacrimation increased (Epiphora) Very Common
Laryngeal oedema Not known
Lethargy Not known
Leucopenia (Leukopenia) Common
Leukaemia Not known
Lip swelling Very Common
Liver tenderness Common
Lung disease Not known
Lung disorder Common
Lung infiltration (pulmonary infiltration) Not known
Lymphoedema Very Common
Maculopapular rash Common
Madarosis Not known
Malaise Common
Mastitis (breast inflammation) Common
Mastodynia Common
Meningitis Not known
Mucosal inflammation Very Common
Muscle cramps Common
Muscle tightness Very Common
Musculoskeletal pain Common
Myalgia Very Common
Nail disorders Common
Nail toxicity Not known
Nasopharyngitis Very Common
Nausea Very Common
Neck pain Common
Neuropathy peripheral Common
Neutropenia Common
Neutropenic sepsis Not known
Obnubilation Very rare
Oedema peripheral Very Common
Oligohydramnios Not known
Onychorrhexis Not known
Oropharyngeal pain Very Common
Orthopnoea Not known
Oxygen saturation decreased Not known
Pain Very Common
Pain in extremity (Pain in limb) Very rare
Palpitations Common
Pancreatitis Common
Papilloedema Not known
Paraesthesia (paresthesia) Very Common
Paraneoplastic cerebellar degeneration Not known
Pericardial effusion Not known
Pericarditis Not known
Pharyngitis Common
Pleural effusion Common
Pneumonia Not known
Progressive malignant neoplasia Not known
Progressive neoplasia Not known
Pruritus Common
Pulmonary fibrosis Not known
Pulmonary hypoplasia Not known
Pyrexia Very Common
Renal disorder Common
Renal hypoplasia Not known
Renal insufficiency Not known
Respiratory arrest Not known
Respiratory distress syndrome Not known
Respiratory failure Not known
Retinal haemorrhage (retinal hemorrhages) Not known
Rhinitis Common
Rhinorrhoea Very Common
Septicemia Not known
Sinusitis Common
Skin Eruption Very Common
Skin infection Common
Somnolence Common
Stevens-Johnson syndrome Not known
Stomatitis Very Common
Supraventricular tachyarrhythmia Common
Tachycardia Not known
Thought disturbances Very rare
Thrombocytopenia (Thrombopenia) Very Common
Tremor Very Common
Upper respiratory tract infection Common
Urinary tract infection Very rare
Urticaria Not known
Vasodilation Common
Vertigo Very Common
Vomiting Very Common
Weight decreased (Weight loss) Very Common
Weight increased (weight gain) Very Common
Wheezing Very Common

Different Units By MoH Code

Revision Date : 01/01/1998

Revision Date : 01/12/2020

Herceptin 440mg Herceptin 440mg Herceptin 440mg Herceptin 440mg Herceptin 440mg Herceptin 440mg

Herceptin 440mg  MoH 8053 :
Form Powder for concentrate for solution for infusion
Packaging Bottle
Package Size Box of 1
Strength 440mg
Public Price 166423475.66 L.L.
Stratum E2
NSSF ✘
Quarantine ✔
Reg. Number 11015/1
Submission date 01/01/2014
Registration Year 2015
Recall date 13/07/2020
Recall Reason National regulatory reasons


Price Comparison

● Country: Qatar
● Package Size: 1+ 1x20ml
● Public Price: 15049 QAR ( 369,573,342.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 15049 QAR ( 369,573,342.00 LBP )
● Pharmacy Price: 12361.8961856 QAR ( 303583446.52596 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 1 Vial (Dry) + 1 Solvent Vial (20ml)
● Public Price: 14062.5 AED ( 339,764,062.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 14062,5 AED ( 339,751,982.00 LBP )
● Pharmacy Price: 11979.47 AED ( 289435974.67 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 1 Vial (Dry) + 1 Solvent Vial (20ml)
● Public Price: 14062.5 AED ( 339,764,062.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 14062,5 AED ( 339,751,982.00 LBP )
● Pharmacy Price: 11979.5 AED ( 289436699.5 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 1
● Public Price: 1295.94 BHD ( 308,088,999.96 LBP )
● Pack size unit used: 1
● Cost/Unit: 1295,94 BHD ( 307,865,530.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: Jordan
● Package Size: 1
● Public Price: 1828.01 JOD ( 228,905,240.21 LBP )
● Pack size unit used: 1
● Cost/Unit: 1828,01 JOD ( 228,903,988.00 LBP )
● Pharmacy Price: 1757.7 JOD ( 220100951.7 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: Oman
● Package Size: 1
● Public Price: 905.08 OMR ( 208,832,728.72 LBP )
● Pack size unit used: 1
● Cost/Unit: 905,08 OMR ( 208,814,270.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 1
● Public Price: 1932.85 CHF ( 199,895,347.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1932,85 CHF ( 199,807,440.00 LBP )
● Exfactory Price: 1706.26 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: Lebanon
● Form: Powder for concentrate for solution for infusion
● Package Size: Box of 1
● Public Price: 166423475.66 LBP ( 166,423,475.66 LBP )
● Pack size unit used: 1
● Cost/Unit: 166423475,66 LBP ( 166,423,475.00 LBP )
● Pricing Date: 03/09/2026

● Country: Cyprus
● Package Size: 1x5ml
● Public Price: 1616.03 EUR ( 156,554,522.28 LBP )
● Pack size unit used: 1
● Cost/Unit: 1616,03 EUR ( 156,551,616.00 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 24/03/2021
● Type: Medicine Authorised

● Country: Egypt
● Package Size: 1
● Public Price: 14630 EGP ( 26,699,750.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 14630 EGP ( 26,699,750.00 LBP )
● Pricing Date: 20/11/2019
● Type: Medicine Authorised

● Country: New Zealand
● Package Size: 1 inj
● Exfactory Price: 3875 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Breast cancer : (Adults)
● Cost/Unit: 15049 QAR ( 369,573,342.00 LBP )
● Cost/Day: 15049 QAR ( 369,573,342.00 LBP )
● Cost/Month: 60196 QAR ( 1,478,293,368.00 LBP )
Metastatic breast cancer : (Adults)
● Cost/Unit: 15049 QAR ( 369,573,342.00 LBP )
● Cost/Day: 15049 QAR ( 369,573,342.00 LBP )
● Cost/Month: 60196 QAR ( 1,478,293,368.00 LBP )
Breast cancer : (Adults)
● Cost/Unit: 14062,5 AED ( 339,751,982.00 LBP )
● Cost/Day: 14062,5 AED ( 339,751,982.00 LBP )
● Cost/Month: 56250 AED ( 1,359,056,250.00 LBP )
Metastatic breast cancer : (Adults)
● Cost/Unit: 14062,5 AED ( 339,751,982.00 LBP )
● Cost/Day: 14062,5 AED ( 339,751,982.00 LBP )
● Cost/Month: 56250 AED ( 1,359,056,250.00 LBP )
Breast cancer : (Adults)
● Cost/Unit: 14062,5 AED ( 339,751,982.00 LBP )
● Cost/Day: 14062,5 AED ( 339,751,982.00 LBP )
● Cost/Month: 56250 AED ( 1,359,056,250.00 LBP )
Metastatic breast cancer : (Adults)
● Cost/Unit: 14062,5 AED ( 339,751,982.00 LBP )
● Cost/Day: 14062,5 AED ( 339,751,982.00 LBP )
● Cost/Month: 56250 AED ( 1,359,056,250.00 LBP )
Breast cancer : (Adults)
● Cost/Unit: 1295,94 BHD ( 307,865,530.00 LBP )
● Cost/Day: 1295,94 BHD ( 307,865,530.00 LBP )
● Cost/Month: 5183,76 BHD ( 1,232,175,322.00 LBP )
Metastatic breast cancer : (Adults)
● Cost/Unit: 1295,94 BHD ( 307,865,530.00 LBP )
● Cost/Day: 1295,94 BHD ( 307,865,530.00 LBP )
● Cost/Month: 5183,76 BHD ( 1,232,175,322.00 LBP )
Breast cancer : (Adults)
● Cost/Unit: 1828,01 JOD ( 228,903,988.00 LBP )
● Cost/Day: 1828,01 JOD ( 228,903,988.00 LBP )
● Cost/Month: 7312,04 JOD ( 915,615,952.00 LBP )
Metastatic breast cancer : (Adults)
● Cost/Unit: 1828,01 JOD ( 228,903,988.00 LBP )
● Cost/Day: 1828,01 JOD ( 228,903,988.00 LBP )
● Cost/Month: 7312,04 JOD ( 915,615,952.00 LBP )
Breast cancer : (Adults)
● Cost/Unit: 905,08 OMR ( 208,814,270.00 LBP )
● Cost/Day: 905,08 OMR ( 208,814,270.00 LBP )
● Cost/Month: 3620,32 OMR ( 835,257,080.00 LBP )
Metastatic breast cancer : (Adults)
● Cost/Unit: 905,08 OMR ( 208,814,270.00 LBP )
● Cost/Day: 905,08 OMR ( 208,814,270.00 LBP )
● Cost/Month: 3620,32 OMR ( 835,257,080.00 LBP )
Breast cancer : (Adults)
● Cost/Unit: 1932,85 CHF ( 199,807,440.00 LBP )
● Cost/Day: 1932,85 CHF ( 199,807,440.00 LBP )
● Cost/Month: 7731,4 CHF ( 799,540,020.00 LBP )
Metastatic breast cancer : (Adults)
● Cost/Unit: 1932,85 CHF ( 199,807,440.00 LBP )
● Cost/Day: 1932,85 CHF ( 199,807,440.00 LBP )
● Cost/Month: 7731,4 CHF ( 799,540,020.00 LBP )
Breast cancer : (Adults)
● Cost/Unit: 166423475,66 LBP ( 166,423,475.00 LBP )
● Cost/Day: 166423475,66 LBP ( 166,423,475.00 LBP )
● Cost/Month: 665693902,64 LBP ( 665,693,902.00 LBP )
Metastatic breast cancer : (Adults)
● Cost/Unit: 166423475,66 LBP ( 166,423,475.00 LBP )
● Cost/Day: 166423475,66 LBP ( 166,423,475.00 LBP )
● Cost/Month: 665693902,64 LBP ( 665,693,902.00 LBP )
Breast cancer : (Adults)
● Cost/Unit: 1616,03 EUR ( 156,551,616.00 LBP )
● Cost/Day: 1616,03 EUR ( 156,551,616.00 LBP )
● Cost/Month: 6464,12 EUR ( 626,206,464.00 LBP )
Metastatic breast cancer : (Adults)
● Cost/Unit: 1616,03 EUR ( 156,551,616.00 LBP )
● Cost/Day: 1616,03 EUR ( 156,551,616.00 LBP )
● Cost/Month: 6464,12 EUR ( 626,206,464.00 LBP )
Breast cancer : (Adults)
● Cost/Unit: 14630 EGP ( 26,699,750.00 LBP )
● Cost/Day: 14630 EGP ( 26,699,750.00 LBP )
● Cost/Month: 58520 EGP ( 106,799,000.00 LBP )
Metastatic breast cancer : (Adults)
● Cost/Unit: 14630 EGP ( 26,699,750.00 LBP )
● Cost/Day: 14630 EGP ( 26,699,750.00 LBP )
● Cost/Month: 58520 EGP ( 106,799,000.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info